Fig. 5From: Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau diseaseRT-PCR results of the miR210 gene as measured from plasma samples of the patients included in the clinical trial. The quantification of miR210 before and after 1/3 months (Pre/Post) of propranolol treatment is presented. All the decreases are significant at p < 0.001Back to article page